Cargando…
The role of single nucleotide polymorphisms related to iron homeostasis in mesothelioma susceptibility after asbestos exposure: a genetic study on autoptic samples
Asbestos-related diseases still represent a major public health problem all over the world. Among them, malignant mesothelioma (MM) is a poor-prognosis cancer, arising from the serosal lining of the pleura, pericardium and peritoneum, triggered by asbestos exposure. Literature data suggest the key r...
Autores principales: | Grignani, Pierangela, Visonà, Silvia Damiana, Fronda, Maria Vittoria, Borrelli, Paola, Monti, Maria Cristina, Bertoglio, Barbara, Conti, Adelaide, Fattorini, Paolo, Previderè, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628177/ https://www.ncbi.nlm.nih.gov/pubmed/37942251 http://dx.doi.org/10.3389/fpubh.2023.1236558 |
Ejemplares similares
-
Genetic individual identification from dried urine spots: A complementary tool to drug monitoring and anti‐doping testing
por: Grignani, Pierangela, et al.
Publicado: (2022) -
Inorganic Fiber Lung Burden in Subjects with Occupational and/or Anthropogenic Environmental Asbestos Exposure in Broni (Pavia, Northern Italy): An SEM-EDS Study on Autoptic Samples
por: Visonà, Silvia Damiana, et al.
Publicado: (2021) -
Reply to Mirabelli et al. Is Mesothelioma Unrelated to the Lung Asbestos Burden? Comment on “Visonà et al. Inorganic Fiber Lung Burden in Subjects with Occupational and/or Anthropogenic Environmental Asbestos Exposure in Broni (Pavia, Northern Italy): An SEM-EDS Study on Autoptic Samples. Int. J. Environ. Res. Public Health 2021, 18, 2053”
por: Visonà, Silvia Damiana, et al.
Publicado: (2021) -
A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases
por: Visonà, S. D., et al.
Publicado: (2023) -
The Baron Pasquale Revoltella’s Will in the Forensic Genetics Era
por: Fattorini, Paolo, et al.
Publicado: (2023)